SCHEMBL660976

SCHEMBL660976

[CH2]c1ccc([N+](=O)[O-])o1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15200988 0.82 LMNA (0.58)
SCHEMBL27853220 0.71
SCHEMBL5948310 0.71
SCHEMBL11391278 0.71
SCHEMBL660977 0.71
SCHEMBL8587843 0.71
SCHEMBL14534706 0.71
SCHEMBL11752214 0.71
SCHEMBL2089914 0.71 LMNA (0.61)
SCHEMBL258450 0.71 KMT2A (0.63)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 113 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021202886-A1 METHODS FOR THE MONO-AMIDATION OF PHOSPHATES AND PHOSPHONATES BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2021-10-07 WO claimed
US-20090018148-A1 Xanthine Derivatives, Processes For Preparing Them And Their Uses UCB PHARMA, S.A. (BE) 2009-01-15 US claimed
EP-1963325-A2 XANTHINE DERIVATIVES, PROCESSES FOR PREPARING THEM AND THEIR USES UCB Pharma, S.A. (BE) 2008-09-03 EP claimed
WO-2007065595-A2 XANTHINE DERIVATIVES, PROCESSES FOR PREPARING THEM AND THEIR USES UCB PHARMA, S.A. (BE) 2007-06-14 WO claimed
US-20240116972-A1 6-AZA-NUCLEOSIDE PRODRUGS AS ANTIVIRAL AGENTS FOR TREATING VIRUS INFECTIONS SOUTHERN RES INST (US) 2024-04-11 US disclosed
US-11858956-B2 6-aza-nucleoside prodrugs as antiviral agents for treating virus infections SOUTHERN RESEARCH INSTITUTE (US) 2024-01-02 US disclosed
US-20230277501-A1 METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION THE JOHNS HOPKINS UNIVERSITY 2023-09-07 US disclosed
EP-4209498-A1 4'-THIO-NUCLEOTIDE AND -NUCLEOSIDE PRODRUGS FOR THE TREATMENT OF CANCER Southern Research Institute (US) 2023-07-12 EP disclosed
US-20230167142-A1 METHODS FOR THE MONO-AMIDATION OF PHOSPHATES AND PHOSPHONATES BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2023-06-01 US disclosed
US-20230033195-A1 METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION THE JOHNS HOPKINS UNIVERSITY 2023-02-02 US disclosed
US-20220218665-A1 METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION UNIV JOHNS HOPKINS (US) 2022-07-14 US disclosed
US-20220204545-A1 6-AZA-NUCLEOSIDE PRODRUGS AS ANTIVIRAL AGENTS FOR TREATING VIRUS INFECTIONS OREGON HEALTH AND SCIENCE UNIVERSITY 2022-06-30 US disclosed
EP-1268493-A1 PHOSPHORAMIDATE PRODRUGS PURDUE RESEARCH FOUNDATION (US) 2003-01-02 EP disclosed
WO-2002102782-A2 QUINAZOLINE DERIVATIVES which PROMOTE THE RELEASE OF PARATHYROID_HORMONE NOVARTIS AG (CH) 2002-12-27 WO disclosed
EP-1198467-A1 5-NITROFURFURAL DERIVATIVES NORSK HYDRO ASA (NO) 2002-04-24 EP disclosed
WO-2001074827-A1 PHOSPHORAMIDATE PRODRUGS PURDUE RESEARCH FOUNDATION (US) 2001-10-11 WO disclosed
WO-2001002412-A1 5-NITROFURFURAL DERIVATIVES NORSK HYDRO ASA (NO) 2001-01-11 WO disclosed
EP-0697022-A1 PHOSPHORAMIDATES USEFUL AS ANTITUMOR AGENTS Research Corporation Technologies, Inc (US) 1996-02-21 EP disclosed
WO-1994025471-A1 PHOSPHORAMIDATES USEFUL AS ANTITUMOR AGENTS RESEARCH CORPORATION TECHNOLOGIES, INC. (US) 1994-11-10 WO disclosed
US-4482759-A Fungicidally active benzhydrol derivatives DEGUSSA AKTIENGESELLSCHAFT (DE) 1984-11-13 US disclosed